Andere talen Albert Labs International Corp. Deutsche Boerse AG

Aandelen

VB50

CA0127841041

Vertraagde tijd Deutsche Boerse AG Andere beurzen 08:12:57 03-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,006 ^EUR	0,00%		+20,00%	+50,00%

2023	Albert Labs International Corp. Rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023	CI
2023	Albert Labs International Corp. Benoemt Shabir Hasham tot lid van de Raad van Bestuur	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Albert Labs International Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11
Albert Labs International Corp. Appoints Shabir Hasham to Its Board of Directors	18-10-23
Albert Labs International Corp. Announces Resignation of Michael Raymont as Board of Directors	05-09-23
Albert Labs International Corp. Announces CEO Changes	05-09-23
Albert Labs International Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28-08-23
Albert Labs International Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	07-06-23
Albert Labs International Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	02-06-23
Albert Labs International Corp. Auditor Raises 'Going Concern' Doubt	02-06-23
Albert Labs International Corp. Announces Preliminary Acceptance of 35 Novel Innovative Claims	02-05-23
Albert Labs International Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29-11-22
Albert Labs Signs Letter of Intent with Ingen CRO for First In-Human Clinical Studies	17-11-22
Albert Labs Files New International PCT Patent Application for Scalable API Manufacturing	20-10-22
Albert Labs International Corp. Announces the Appointment of Mike Thompson MBE and Katie Shelton-Innes to Its Board	11-07-22
Albert Labs International Corp. Auditor Raises 'Going Concern' Doubt	09-06-22
Albert Labs International Corp. Grants Health Canada License	16-05-22
Albert Labs International Corp.' Pre-Clinical Analytical and Toxicological Research Supports Company's Forthcoming Studies	12-05-22
Albert Labs International Corp. Announces Board Appointments	26-04-22
Albert Labs International Corp. Files US Provisional Patent Application and Proves Out Consistent and Rapidly Scalable Production of Psilocybe and Other Mycelia	30-03-22
Albert Labs International Corp. Auditor Raises 'Going Concern' Doubt	15-03-22
Albert Labs Inc. completed the acquisition of ME Resource Corp. in a reverse merger transaction.	10-03-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Albert Labs International Corp. Deutsche Boerse AG

Aandelen

VB50

CA0127841041

Andere talen

Filters